Trinity Biotech plc each representing 4 A Ordinary Shares (TRIB) Social Stream
Trinity Biotech Plc (TRIB) Price Targets From Analysts
Use the tables below to see what analysts covering Trinity Biotech Plc think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 1 | $5 | $5 | $5 | $2.09 | 139.23% |
Price Target Last Issued November 8, 2020
TRIB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- The number of analysts covering the stock of TRIB is greater than just about none of of all US stocks.
- Trinity Biotech Plc's variance in analysts' estimates is less than just about 100% of all US stocks.
- The average analyst price target of TRIB is greater than 7.72% of all US stocks.
- TRIB has a greater upside potential (average analyst target price relative to current price) than 85.35% of all US stocks.
What is the outlook for TRIB? Use POWR Ratings for clearer insight into price direction.